182 related articles for article (PubMed ID: 21881029)
1. Cryptotanshinone inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3/ERK and small GTPase pathways.
Luo Y; Chen W; Zhou H; Liu L; Shen T; Alexander JS; Zheng S; Lu Y; Huang S
Cancer Prev Res (Phila); 2011 Dec; 4(12):2083-91. PubMed ID: 21881029
[TBL] [Abstract][Full Text] [Related]
2. The fungicide ciclopirox inhibits lymphatic endothelial cell tube formation by suppressing VEGFR-3-mediated ERK signaling pathway.
Luo Y; Zhou H; Liu L; Shen T; Chen W; Xu B; Han X; Zhang F; Scott RS; Alexander JS; Alam A; Huang S
Oncogene; 2011 May; 30(18):2098-107. PubMed ID: 21217783
[TBL] [Abstract][Full Text] [Related]
3. Sunitinib inhibits lymphatic endothelial cell functions and lymph node metastasis in a breast cancer model through inhibition of vascular endothelial growth factor receptor 3.
Kodera Y; Katanasaka Y; Kitamura Y; Tsuda H; Nishio K; Tamura T; Koizumi F
Breast Cancer Res; 2011 Jun; 13(3):R66. PubMed ID: 21693010
[TBL] [Abstract][Full Text] [Related]
4. Cryptotanshinone activates p38/JNK and inhibits Erk1/2 leading to caspase-independent cell death in tumor cells.
Chen W; Liu L; Luo Y; Odaka Y; Awate S; Zhou H; Shen T; Zheng S; Lu Y; Huang S
Cancer Prev Res (Phila); 2012 May; 5(5):778-87. PubMed ID: 22490436
[TBL] [Abstract][Full Text] [Related]
5. Vascular endothelial growth factor receptor-3 directly interacts with phosphatidylinositol 3-kinase to regulate lymphangiogenesis.
Coso S; Zeng Y; Opeskin K; Williams ED
PLoS One; 2012; 7(6):e39558. PubMed ID: 22745786
[TBL] [Abstract][Full Text] [Related]
6. Rapamycin inhibits lymphatic endothelial cell tube formation by downregulating vascular endothelial growth factor receptor 3 protein expression.
Luo Y; Liu L; Rogers D; Su W; Odaka Y; Zhou H; Chen W; Shen T; Alexander JS; Huang S
Neoplasia; 2012 Mar; 14(3):228-37. PubMed ID: 22496622
[TBL] [Abstract][Full Text] [Related]
7. Cryptotanshinone inhibits VEGF-induced angiogenesis by targeting the VEGFR2 signaling pathway.
Xu X; Wu L; Zhou X; Zhou N; Zhuang Q; Yang J; Dai J; Wang H; Chen S; Mao W
Microvasc Res; 2017 May; 111():25-31. PubMed ID: 28040437
[TBL] [Abstract][Full Text] [Related]
8. Molecular controls of lymphatic VEGFR3 signaling.
Deng Y; Zhang X; Simons M
Arterioscler Thromb Vasc Biol; 2015 Feb; 35(2):421-9. PubMed ID: 25524775
[TBL] [Abstract][Full Text] [Related]
9. Regulation of osteoclast apoptosis and motility by small GTPase binding protein Rac1.
Fukuda A; Hikita A; Wakeyama H; Akiyama T; Oda H; Nakamura K; Tanaka S
J Bone Miner Res; 2005 Dec; 20(12):2245-53. PubMed ID: 16294277
[TBL] [Abstract][Full Text] [Related]
10. Cdc42 and k-Ras Control Endothelial Tubulogenesis through Apical Membrane and Cytoskeletal Polarization: Novel Stimulatory Roles for GTPase Effectors, the Small GTPases, Rac2 and Rap1b, and Inhibitory Influence of Arhgap31 and Rasa1.
Norden PR; Kim DJ; Barry DM; Cleaver OB; Davis GE
PLoS One; 2016; 11(1):e0147758. PubMed ID: 26812085
[TBL] [Abstract][Full Text] [Related]
11. Cdc42 downregulates MMP-1 expression by inhibiting the ERK1/2 pathway.
Deroanne CF; Hamelryckx D; Ho TT; Lambert CA; Catroux P; Lapière CM; Nusgens BV
J Cell Sci; 2005 Mar; 118(Pt 6):1173-83. PubMed ID: 15728253
[TBL] [Abstract][Full Text] [Related]
12. Phosphorylation of tyrosine 1214 on VEGFR2 is required for VEGF-induced activation of Cdc42 upstream of SAPK2/p38.
Lamalice L; Houle F; Jourdan G; Huot J
Oncogene; 2004 Jan; 23(2):434-45. PubMed ID: 14724572
[TBL] [Abstract][Full Text] [Related]
13. RHOG Activates RAC1 through CDC42 Leading to Tube Formation in Vascular Endothelial Cells.
El Atat O; Fakih A; El-Sibai M
Cells; 2019 Feb; 8(2):. PubMed ID: 30781697
[TBL] [Abstract][Full Text] [Related]
14. Rac1 modulates sphingosine 1-phosphate-mediated activation of phosphoinositide 3-kinase/Akt signaling pathways in vascular endothelial cells.
Gonzalez E; Kou R; Michel T
J Biol Chem; 2006 Feb; 281(6):3210-6. PubMed ID: 16339142
[TBL] [Abstract][Full Text] [Related]
15. Flt-1-mediated down-regulation of endothelial cell proliferation through pertussis toxin-sensitive G proteins, beta gamma subunits, small GTPase CDC42, and partly by Rac-1.
Zeng H; Zhao D; Mukhopadhyay D
J Biol Chem; 2002 Feb; 277(6):4003-9. PubMed ID: 11726672
[TBL] [Abstract][Full Text] [Related]
16. ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice.
Spirli C; Okolicsanyi S; Fiorotto R; Fabris L; Cadamuro M; Lecchi S; Tian X; Somlo S; Strazzabosco M
Gastroenterology; 2010 Jan; 138(1):360-371.e7. PubMed ID: 19766642
[TBL] [Abstract][Full Text] [Related]
17. VEGFR-3 signaling is regulated by a G-protein activator, activator of G-protein signaling 8, in lymphatic endothelial cells.
Sakima M; Hayashi H; Mamun AA; Sato M
Exp Cell Res; 2018 Jul; 368(1):13-23. PubMed ID: 29649427
[TBL] [Abstract][Full Text] [Related]
18. Ras/MAPK signaling modulates VEGFR-3 expression through Ets-mediated p300 recruitment and histone acetylation on the Vegfr3 gene in lymphatic endothelial cells.
Ichise T; Yoshida N; Ichise H
PLoS One; 2012; 7(12):e51639. PubMed ID: 23284731
[TBL] [Abstract][Full Text] [Related]
19. S1P1 and VEGFR-2 form a signaling complex with extracellularly regulated kinase 1/2 and protein kinase C-alpha regulating ML-1 thyroid carcinoma cell migration.
Bergelin N; Löf C; Balthasar S; Kalhori V; Törnquist K
Endocrinology; 2010 Jul; 151(7):2994-3005. PubMed ID: 20501673
[TBL] [Abstract][Full Text] [Related]
20. uPARAP/Endo180 receptor is a gatekeeper of VEGFR-2/VEGFR-3 heterodimerisation during pathological lymphangiogenesis.
Durré T; Morfoisse F; Erpicum C; Ebroin M; Blacher S; García-Caballero M; Deroanne C; Louis T; Balsat C; Van de Velde M; Kaijalainen S; Kridelka F; Engelholm L; Struman I; Alitalo K; Behrendt N; Paupert J; Noel A
Nat Commun; 2018 Dec; 9(1):5178. PubMed ID: 30518756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
